Gps Wealth Strategies Group, LLC Xeris Biopharma Holdings, Inc. Transaction History
Gps Wealth Strategies Group, LLC
- $705 Million
- Q1 2025
A detailed history of Gps Wealth Strategies Group, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 66,925 shares of XERS stock, worth $269,038. This represents 0.05% of its overall portfolio holdings.
Number of Shares
66,925
Previous 66,925
-0.0%
Holding current value
$269,038
Previous $226,000
62.39%
% of portfolio
0.05%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding XERS
# of Institutions
165Shares Held
61MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$41.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$31.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$13.5 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$13.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$11.6 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $547M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...